Overview

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The study is about possible protective effects of paricalcitol (Zemplar) upon inflammation, blood pressure and kidney function. Kidney Inflammation occurs when white blood cells become abnormally stimulated and accumulate in the kidney and cause damage to the kidney. The purpose of this study is to determine if paricalcitol helps improve kidney injury, blood pressure control and kidney function in patients with chronic kidney disease. The study will last about 7 weeks and involves about 8 visits to the medical center.
Phase:
N/A
Details
Lead Sponsor:
Indiana University School of Medicine
Collaborator:
Abbott
Treatments:
Ergocalciferols